Adhesive plaster for curing neurodermatitis

Abstract

The present inventino provides an adhesive plaster preparation for curing neurodermatitis. It includes mounting layer, plaster surface covering layer and plaster material, and is characterized by that the composition of said plaster material includes (wt%) 0.5-5% of dyclonine, 0.25-5% of diphenhydranine and 90-99.25% of matrix. Its cure rate is high, and it has no any side effects.

Description

technical field [0001] The present invention relates to preparations for medical use, in particular topical preparations for the treatment of neurodermatitis. Background technique [0002] Neurodermatitis is a refractory and easily recurring skin nerve dysfunction skin disease. The clinical manifestations are characterized by lichenification and severe itching, accompanied by neurological abnormalities such as neurasthenia, insomnia, dreaminess, forgetfulness, and mood swings. Clinically, the rash and mental symptoms are mutually causal, often leading to a vicious circle, which brings great pain to the patient both mentally and physically. At present, when clinically treating neurodermatitis, the most commonly used drugs are external preparations containing corticosteroid hormones, such as triamcinolone ointment and Fujining (containing triamcinolone acetate-A) plaster. Though these medicines have certain curative effect, need medication for a long time and easily relapse ...

AI Technical Summary

Problems solved by technology

Although these drugs have a certain therapeutic effect, they need to be used for a long time and are prone to relapse after drug withdrawal, and sometimes the disease can be aggravated

In addition, corticosteroids themselves have certain side effects. Long-term use of corticosteroids for external use can lead to atrophy of the epidermis and dermis, thinning of the skin, and adverse reactions such as skin wrinkles, telangiectasia, and purpura.

Images